Related Experiment Video
Updated: Jul 22, 2026

10:12
Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
Published on: January 10, 2019
19.0K
Spatial Location of SPP1+TAMs and Mutually Exclusive Subsets Based on Single-Cell and Transcriptome Data
Xuan Luo1, JianGuo Xu2, ZhiYuan Wang1
1Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Cancer Science
|November 22, 2025
Summary
Secreted phosphoprotein-1 (SPP1)+ tumor-associated macrophages (TAMs) and MARCO+ M2 macrophages represent distinct subsets in lung adenocarcinoma (LUAD). These subsets, SPP1+ M2 and MARCO+ M2, play roles in different stages of LUAD progression.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Lung adenocarcinoma (LUAD) progression involves complex cellular interactions.
- Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment.
- Understanding TAM subsets is crucial for targeted LUAD therapies.
Purpose of the Study:
- To delineate the distinct subsets and spatial locations of SPP1+ TAMs in LUAD.
- To analyze the polarization, cellular subsets, and spatial distribution of SPP1+ TAMs.
- To provide a basis for precision treatment strategies in LUAD.
Main Methods:
- Analysis of transcriptome data from TCGA, GTEx, and GEO databases.
- Single-cell and spatial transcriptome analysis.
- Immunohistochemical analysis using HPA and local LUAD samples.
Main Results:
- SPP1 is identified as a central regulatory gene in LUAD.
- SPP1+ M2 macrophages are associated with invasive lung carcinoma (ILC), while MARCO+ M2 macrophages are linked to adenocarcinoma in situ (AIS).
- SPP1+ M2 macrophages are located at the tumor edge, potentially increasing invasiveness, and are spatially distinct from MARCO+ M2 macrophages.
Conclusions:
- SPP1+ M2 and MARCO+ M2 macrophages form mutually exclusive subsets in LUAD.
- These distinct macrophage subsets synergistically promote different stages of LUAD progression.
- Targeting these specific TAM subsets may offer novel therapeutic avenues for LUAD.

